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1. INTRODUCTION {#brb31336-sec-0005}
===============

Chronic obstructive pulmonary disease (COPD) is a common chronic lung disease characterized by incompletely reversible airflow limitation, with shortness of breath and productive cough as main symptoms. There is an increasing recognition that COPD is more than a simple respiratory disorder and associated with many social and psychological problems which include depression, anxiety, and cognitive impairment (CI; Dodd, Getov, & Jones, [2010](#brb31336-bib-0010){ref-type="ref"}; Eisner et al., [2011](#brb31336-bib-0012){ref-type="ref"}; Fried, Vaz Fragoso, & Rabow, [2012](#brb31336-bib-0015){ref-type="ref"}). CI can lead to problems with adherence to treatment, self‐management, and educational achievement (Cleutjens, Spruit, et al., [2017](#brb31336-bib-0006){ref-type="ref"}; Sulaiman et al., [2017](#brb31336-bib-0032){ref-type="ref"}). Meanwhile, impaired performance in neuropsychological tests had been suggested to be a predictor of mortality and disability (Antonelli‐Incalzi et al., [2006](#brb31336-bib-0025){ref-type="ref"}). According to the report of Chang et al., COPD patients with CI had a rate of death nearly three times as high as the sum of COPD patients without CI and patients only had CI in their hospitalization (Chang, Chen, McAvay, & Tinetti, [2012](#brb31336-bib-0002){ref-type="ref"}).

The pathogenesis of CI in COPD patients is largely unknown. Possible mechanisms contributing to CI in COPD include inflammation and small vascular disease mediated through chronic hypoxia, heavy metals, nicotine accumulation caused by cigarette smoke, and other comorbidities (Dodd et al., [2010](#brb31336-bib-0010){ref-type="ref"}; Lahousse, Tiemeier, Ikram, & Brusselle, [2015](#brb31336-bib-0022){ref-type="ref"}). Different pathways in COPD pathogenesis may affect different brain regions associated with different brain functions and may lead to a pattern of cognitive dysfunction specific to COPD. There have been some studies concerning the subtypes of MCI (mild cognitive impairment) or specific affected cognitive domains in the COPD patients (Cleutjens, Franssen, et al., [2017](#brb31336-bib-0004){ref-type="ref"}; Singh et al., [2014](#brb31336-bib-0029){ref-type="ref"}, [2013](#brb31336-bib-0030){ref-type="ref"}; Villeneuve et al., [2012](#brb31336-bib-0035){ref-type="ref"}). Most of these studies indicate that COPD patients with an increased risk of na‐MCI (non‐amnestic MCI), while an increased risk of a‐MCI (amnestic MCI) has also been reported. Thus, it is still of importance to investigate the affected domains of cognitive function specific to COPD for a better understanding of the pattern of CI in COPD.

Meanwhile, a few studies have attempted to explore the brain pathology involving the brain structural change and vascular disease in the COPD patient through MRI (Cleutjens, Ponds, et al., [2017](#brb31336-bib-0005){ref-type="ref"}; Wang et al., [2017](#brb31336-bib-0036){ref-type="ref"}). However, the number of such studies is still small and the conclusions are lack of agreement. Studies incorporating structural and functional MRI can provide more comprehensive information for the underlying mechanism of the various pathways in the pathogenesis of CI (Dodd et al., [2012](#brb31336-bib-0009){ref-type="ref"}). Chronic hypoxia is supposed to be the most important part for the neuronal damage through inflammation and atherosclerosis in the COPD (Dodd et al., [2010](#brb31336-bib-0010){ref-type="ref"}). Spontaneous or task‐related neuronal activity is also reported to be suppressed under both experimental and chronic hypoxia environment (Gavello et al., [2012](#brb31336-bib-0016){ref-type="ref"}; Goodall, Twomey, & Amann, [2014](#brb31336-bib-0017){ref-type="ref"}; Sicard & Duong, [2005](#brb31336-bib-0028){ref-type="ref"}; Sumiyoshi, Suzuki, Shimokawa, & Kawashima, [2012](#brb31336-bib-0033){ref-type="ref"}). Amplitude of low‐frequency fluctuation (ALFF) is a resting‐state functional MRI (rs‐fMRI) method which may serve as a surrogate for neural activity at single‐voxel level (Cui et al., [2014](#brb31336-bib-0007){ref-type="ref"}; Zang et al., [2007](#brb31336-bib-0038){ref-type="ref"}). Given that, an analysis of ALFF may provide important information for the spontaneous neuronal activity pattern specific to the COPD and the difference between COPD patients and healthy controls.

In this study, we seek to determine the domains of cognitive function impaired in the COPD patients again and explore the brain areas showing difference in ALFF between groups of COPD patients and healthy controls. We also try to investigate the possible relationship between alteration in ALFF and the affected cognitive function as well as lung function test using correlation analysis. Meanwhile, supplemental oxygen is commonly adopted as an auxiliary therapy at home for COPD patients. However, it still remains to be explored whether home oxygen therapy will have a direct impact on the brain activity pattern in COPD patients. Moreover, considering the impact of both hypoxia and hyperoxia in the spontaneous blood oxygen level‐dependent (BOLD) signal, we attempted to explore whether concurrent oxygen inhalation will affect ALFF in brain areas showing difference between COPD patients and healthy controls (Bulte, [2016](#brb31336-bib-0001){ref-type="ref"}). This may help to increase our knowledge of the physiologic origin of ALFF and shed some light on the mechanism of the effect of home oxygen therapy.

2. MATERIALS AND METHODS {#brb31336-sec-0006}
========================

2.1. Participants {#brb31336-sec-0007}
-----------------

This study was approved by the Institutional Ethics Committee of Zhongda Hospital, Medical School of Southeast University (Nanjing, China). Written informed consent was given to all the participants.

A total of 28 stable stage COPD patients and 26 age, sex, and education level matched healthy controls were enrolled in this study from 2014 to 2017. All the patients were undergoing drug therapy at home before and during the study. The drugs include long‐acting beta agonists, inhaled corticosteroids, and tiotropium bromide. Exclusion criteria include patients with acute exacerbation of COPD, patients with dementia, patients with diagnoses of other neuropsychiatric diseases, history of brain surgery, alcohol or drug abuse, history of recent use of drugs affecting cognitive functions (less than 2 months), diabetes patients, patients with obstructive sleep apnea‐hypopnea syndrome and contraindications to MR examinations. All the subjects were enrolled from the local community and have an education level of primary school at least.

2.2. Laboratory tests {#brb31336-sec-0008}
---------------------

Spirometry tests without bronchodilator were performed to evaluate the function of pulmonary ventilation on all the participants within 1 week before MRI examination. At the same time, the COPD patients also underwent an arterial blood gas analysis to ensure that they were not hypoxemic or hypercapnic patients. Subjects who could not finish the spirometry tests would not be enrolled for the next MR scan section.

2.3. Neuropsychological assessments {#brb31336-sec-0009}
-----------------------------------

Neuropsychological tests including Mini‐Mental State Examination (MMSE) Test, the Montreal Cognitive Assessment (MoCA) Test, Complex Figure Test (CFT), Auditory Verbal Learning Test (AVLT), Digit Span Test (DST), Digit Symbol Substitution Test (DSST), Trail‐Making Test (TMT‐A and TMT‐B) were assessed 2 hours before MRI in all the participants. The CFT has a recognition section and a recall section. The time used for recognition section of the CFT was also recorded.

2.4. MR imaging data acquisition {#brb31336-sec-0010}
--------------------------------

MR imaging data were acquired with a Siemens 3‐T Trio scanner (Erlangen, Germany) at the Radiology Department of Zhongda Hospital. A gradient‐echo planar sequence was used to acquire the BOLD fMRI images using the following parameters: 36 slices; repetition time, 2,000 ms; echo time, 25 ms; slice thickness, 4 mm; flip angle, 90°; field of view, 240 mm × 240 mm; in‐plane resolution, 64 × 64; repetition, 180; Time to Acquisition, 6 min). Structural images were obtained using a 3D T1‐weighted spoiled gradient‐recalled sequence (sagittal; field of view, 256 × 256 mm; in‐plane resolution, 256 × 256; 176 slices; slice thickness, 1 mm; repetition time, 1,900 ms; echo time, 2.48 ms; inversion time, 900 ms; flip angle, 9°; and section gap, 0 mm). Fluid‐attenuated inversion recovery (FLAIR) images were also obtained for evaluation of cerebral vessel disease (repetition time, 8,500 ms; echo time, 94 ms; 20 slices; slice thickness, 5 mm; in‐plane resolution, 256 × 256; voxel size, 0.45 × 0.45 × 5 mm^3^).

To assess the impact of supplementary oxygen using for the ALFF values, a subset of participants including eight COPD patients and eight controls underwent two rs‐fMRI runs. In the first run, all the subjects breathed freely with room air. Before the second run, 100% O~2~ had been delivered with a flow rate of 2.5 L/min (FiO~2~ = 0.31) through a nasal cannula to the participants for about 25 min and continued until the end of the fMRI session. The normal controls were under moderate hyperoxia during the second run.

2.5. Cerebral small vessel disease assessment {#brb31336-sec-0011}
---------------------------------------------

White matter change (WMC) was assessed on T2WI, T1WI, and FLAIR images with a rating scale described previously (25). Participants with a whole brain rating score \>4 (the sum of white matter and basal ganglia rating score) were excluded from the experiment. Two radiologists (with 3‐ and 5‐year experience) blinded to the group allocations performed the ratings separately. Consensus was achieved through consultation to a senior radiologist with 10‐year experience.

2.6. Image data processing {#brb31336-sec-0012}
--------------------------

All the images were preprocessed based on Statistical Parametric Mapping software (SPM8, <http://www.fil.ion.ucl.ac.uk/spm/>). Structural images and functional images were preprocessed with the Data Processing Assistant for Resting‐State Functional MR Imaging toolbox (DPARSF; <http://www.restfmri.net/forum/DPARSF>). The preprocessing steps for functional images included the following: eliminating the first 10 points, slice timing correction, realignment for head motion correction, spatial normalization, spatial smoothness with an isotropic Gaussian kernel (FWHM = 4 mm), and nuisance covariates regression for the drift terms, head motion parameters, CSF signals, and white matter signals. Any subjects with head motion \>2.0 mm translation or \>2.0° rotation were excluded. The DARTEL method was used for the segmentation of 3D T1 images and normalization of both functional and structural images. A band‐pass filtering (0.01--0.1 Hz) was performed in the BOLD images and the ALFF values of each voxel were calculated using a rs‐fMRI data analysis toolkit (REST1.8, <http://www.restfmri.net>).

2.7. Statistical analysis {#brb31336-sec-0013}
-------------------------

A one‐sample *t* test was performed on the normalized ALFF (subtract mean divide by standard deviation, zALFF) images of the COPD group to review the brain areas of the significant higher ALFF (*p* \< 0.005, AlphaSim corrected). Voxel‐wise two‐sample *t* tests were performed in both the gray matter volume images and zALFF images between the COPD group and control group, with age, education levels, smoking (pack‐years), and whole brain WMC rating score as covariates. Multiple comparison corrections were performed using family‐wise error rate correction with a cluster defining threshold *p* = 0.001 (two tail), corresponding to a cluster level of *p* = 0.05. The cluster showing difference in the two‐sample *t* test was served as ROI to extract the zALFF value for further analysis.

Except for image data, all the other data were analyzed using The SPSS 18.0 software (SPSS Inc. Chicago, IL). The Student\'s *t* test and the Mann--Whitney *U* test were used to compare normally distributed and non‐normally distributed group values respectively. The chi‐squared test was used to detect gender significance between groups. Paired *t* test was used to detect the difference of zALFF values before and after oxygen inhalation. The Pearson correlations were utilized to explore the relationship between zALFF values and neuropsychological performance as well as other clinical indexes showing group difference. Multiple correlations were corrected by the FDR (False Discovery Rate) correction.

3. RESULTS {#brb31336-sec-0014}
==========

3.1. Demographic and clinical profiles {#brb31336-sec-0015}
--------------------------------------

Two COPD patients and four healthy controls were excluded because of excessive head motion. The clinical profile of remaining subjects is summarized in Table [1](#brb31336-tbl-0001){ref-type="table"}. All the subjects enrolled in this study are male. There were no significant differences in age or years of education between COPD patients and healthy controls. The control group had smoked significantly less than COPD patients regarding both pack‐years and ratio of smokers (*p* = 0.01). In pulmonary function test, the COPD patients performed significantly worse than the healthy controls. The profile of FEV1%pred (predicted % forced expiratory volume in 1 min) indicated a moderate airway obstruction in COPD patients. Moderate hypoxemia (82.55% ± 11.90%) were observed in the COPD patients and mean PaCO~2~ were in the normal range (38.29% ± 5.26%). But the SaO~2~ was significantly lower in COPD patients than in healthy controls. In the cerebral vessel disease assessment, there were more subcortical lesions in COPD patients. The COPD patients had a worse performance in the general cognitive impairment (MMSE and MoCA) tests than the healthy controls. When referring to the specific domains, COPD patients got lower scores in the reverse DST, DSST, TMT‐A, and TMT‐B tests. Meanwhile, patients with COPD spent more time on the recognition section of CFT than healthy controls.

###### 

Clinical profile of COPD patients and controls

                                    COPD patients (*n* = 26)   Controls (*n* = 22)   *P*‐value
  --------------------------------- -------------------------- --------------------- -----------
  Age (years)                       63.12 ± 5.3                61.68 ± 4.63          0.335
  Sex (m/f)                         26/0                       22/0                  NA
  Years of education                9.73 ± 2.20                10.41 ± 2.26          0.299
  Disease duration                  9.63 ± 7.81                NA                    NA
  COPD staging (*n*)                                           NA                    NA
  Very mild (FEV~1~%pred ≥ 80)      2                          NA                    NA
  Moderate (FEV~1~%pred 50--79)     7                          NA                    NA
  Severe (FEV~1~%pred 30--49)       9                          NA                    NA
  Very severe (FEV~1~%pred \< 30)   8                          NA                    NA
  Smoking (y/n)                     22/4                       11/11                 0.01
  Smoking (Pack‐years)              35.20 ± 24.04              14.64 ± 16.93         0.002
  SaO~2~ (%)                        94.70 ± 3.46               97.64 ± 1.13          \<0.001
  Spirometry                                                                          
  FVC%pred                          67.34 ± 21.95              100.32 ± 10.55        \<0.001
  FEV~1~%pred                       48.00 ± 25.16              101.24 ± 14.06        \<0.001
  FEV~1~/FVC (%)                    51.11 ± 14.57              79.41 ± 6.34          \<0.001
  Blood gas analysis                                                                  
  PaO~2~ (%)                        82.55 ± 11.90              NA                    NA
  PaCO~2~ (%)                       38.29 ± 5.26               NA                    NA
  WMC rating score                                                                    
  White matter                      1 (0--2)                   1 (0--2)              0.009
  Basal ganglia                     0.5 (0--2)                 0 (0--2)              0.017
  Whole brain                       2 (0--4)                   1 (0--4)              0.002
  Neuropsychological tests                                                            
  MMSE                              26.15 ± 1.51               27.81 ± 1.37          \<0.001
  MoCA                              21.17 ± 3.86               24.09 ± 2.65          0.004
  CFT recognition                   34.54 ± 3.22               35.36 ± 1.29          0.267
  CFT‐delayed recall (20 min)       13.88 ± 6.05               16.09 ± 7.00          0.247
  Task time for CFT recognition     198.35 ± 56.92             153.73 ± 53.97        0.008
  AVLT                              14.12 ± 3.38               14.45 ± 3.51          0.736
  AVLT‐delayed recall (20 min)      7.77 ± 4.75                9.63 ± 3.32           0.114
  Forward DST                       13.54 ± 2.61               14.00 ± 2.02          0.503
  Reverse DST                       6.84 ± 1.99                8.23 ± 1.41           0.009
  DSST                              29.46 ± 9.72               38.31 ± 10.30         0.004
  TMT‐A                             62.71 ± 18.04              52.50 ± 14.92         0.018
  TMT‐B                             167.23 ± 49.10             135.40 ± 29.12        0.011

Data were presented as mean ± *SD* or median (range).

Abbreviations: SaO~2~, Oxygen Saturation of Arterial Blood; WMC, White matter change; FVC, Forced Vital Capacity; FEV1, Forced Expiratory Volume in the first second; FVC%pred, ratio of FVC to predicted FVC; FEV~1~%pred, ratio of FEV~1~ to predicted FEV~1~; PaO~2~, Partial Pressure of Oxygen; PaCO~2~, Partial Pressure of Carbon Dioxide; MMSE, Mini‐Mental State Examination; MoCA, Montreal Cognitive Assessment; CFT, Complex Figure Test; AVLT, Auditory Verbal Learning Test; DST, Digit Span Test; DSST, Digit Symbol Substitution Test; TMT‐A, Trail‐making test‐A; TMT‐B, Trail‐making test‐B.
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3.2. Structural and functional MRI result {#brb31336-sec-0016}
-----------------------------------------

No significant difference was observed in regional gray matter (GM) volume or white matter (WM) volume in the voxel‐wise analysis after multiple comparison correction between COPD patients and control group. There was also no significant difference in the total GM volume and total WM volume (Table [2](#brb31336-tbl-0002){ref-type="table"}).

###### 

Total gray matter and white matter volume

                     COPD           Control       *p*
  ------------------ -------------- ------------- ------
  Total GM volume    0.68 ± 0.048   0.71 ± 0.06   0.15
  Total WM volume    0.52 ± 0.04    0.53 ± 0.05   0.42
  Brain Parenchyma   1.21 ± 0.09    1.24 ± 0.11   0.25

GM, gray matter; WM, white matter.

John Wiley & Sons, Ltd

In one‐sample *t* test of the ALFF map, the posterior cingulate cortex, precuneus, and medial prefrontal cortex demonstrate a significantly higher ALFF value than the global mean in both groups, which resembles the pattern of the default mode network (Figure [1](#brb31336-fig-0001){ref-type="fig"}). Compared to healthy control, decreased ALFF values were mainly found in the bilateral basal ganglia areas including caudate, putamen and pallidum in COPD patients (Figure [2](#brb31336-fig-0002){ref-type="fig"}). Meanwhile, the right thalamus also exhibited lower ALFF in the COPD patients than that in controls. Detailed information of clusters showing difference in two‐sample *t* test is summarized in Table [3](#brb31336-tbl-0003){ref-type="table"}.

![One‐sample *t* test s of ALFF map in COPD group and control group. T maps showing areas (Red color) in which ALFF value is significantly greater than whole brain mean are listed on the upper panel for COPD group, and bottom panel for Control group. Those areas mainly include the posterior cingulate cortex (PCC), precuneus (PCu), and medial prefrontal cortex (mPFC) which resembles the pattern of default‐mode network. No apparent difference was observed in the basic patterns of ALFF between the two groups](BRB3-9-e01336-g001){#brb31336-fig-0001}

![Two‐sample *t* test of ALFF map between COPD group and control group. Decreased ALFF values were mainly located in the bilateral caudate, putamen, pallidum, and thalamus in COPD patients](BRB3-9-e01336-g002){#brb31336-fig-0002}

###### 

Clusters of two‐sample *t* test of zALFF images between COPD patients and controls

  Cluster                        Brain areas (AAL)   Voxel Size   Peak Coordinate   Area of peak voxel   *z*‐Peak               
  ------------------------------ ------------------- ------------ ----------------- -------------------- ---------- ----------- -------
  1                              R Putamen           90           14                14                   3          R Caudate   −5.22
  R Thalamus                     27                                                                                             
  R Caudate                      22                                                                                             
  R Pallidum                     10                                                                                             
  R Other areas (including WM)   87                                                                                             
  2                              L Putamen           88           −18               9                    6          R Putamen   −5.1
  L Pallidum                     10                                                                                             
  L Caudate                      7                                                                                              
  L Other areas (including WM)   59                                                                                             

WM, white matter.
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3.3. Correlation analysis {#brb31336-sec-0017}
-------------------------

ALFF values were extracted from all the subjects using the clusters showing significant difference in the two‐sample *t* test as ROI. The ALFF value correlated closely with the pulmonary function performance and particularly with FEV1%pred (*r* = 0.702, *p* \< 0.0001; *r* = 0.672, *p* \< 0.0001; and *r* = 0.613, *p* \< 0.0001 for FEV1%pred, FEV1/FVC and FVC%pred respectively, Figure [3](#brb31336-fig-0003){ref-type="fig"}). The correlation of pulmonary function performance and the ALFF value remains significant when the analysis were performed in the COPD group (*r* = 0.601, *p* = 0.002; *r* = 0.602, *p* = 0.002 for FEV1%pred and FEV1/FVC respectively) but not in the control group. Meanwhile, the ALFF value correlated with PaO~2~ in the COPD group (*r* = 0.581, *p* = 0.003). The ALFF value also correlated with MMSE test (*r* = 0.383, *p* = 0.009) and task time for CFT recognition (*r* = −0.373, *p* = 0.011), although it did not reach significance after correction for multiple comparison. Furthermore, the correlations between ALFF value and PaO~2~or neuropsychological test performance did not exist after controlling the FEV1%pred. And then, we investigated the relationship between FEV1%pred and neuropsychological test performance (Figure [3](#brb31336-fig-0003){ref-type="fig"}) and found that FEV1%pred significantly correlated with MMSE test (*r* = 0.426, *p* = 0.003) and task time for CFT recognition (*r* = −0.438, *p* = 0.002). The correlation remained significant after controlling for the smoking and small cerebral vessel disease (*r* = 0.371, *p* = 0.013; *r* = −0.402, *p* = 0.006 for correlation with MMSE performance and task time for CFT recognition). The correlation coefficient between the ALFF value and FEV1%pred remained significant after controlling PaO~2~in the COPD group.

![Correlation analysis between aberrant ALFF value and clinical indexes. Aberrant ALFF value correlates with PaO~2~ in COPD group and correlates closely with FEV1%pred in all subjects (a and b, respectively). FEV1%pred correlates with task time for CFT recognition and MMSE as well (c and d, respectively)](BRB3-9-e01336-g003){#brb31336-fig-0003}

3.4. Alteration in ALFF after oxygen inhalation {#brb31336-sec-0018}
-----------------------------------------------

A subset of subjects including eight COPD patients and eight controls underwent a second run with oxygen delivered concurrently through a nasal cannula during MRI session. ALFF values were extracted from all the subjects using the same ROI of correlation analyses and compared between the first run and the second run within each group. After oxygen inhalation, the ALFF value of basal ganglia and right thalamus significantly increased in the control group (*T* = −2.57, *p* = 0.037, Figure [4](#brb31336-fig-0004){ref-type="fig"}), but not in the COPD group (*T* = −0.556, *p* = 0.596).

![Change in ALFF in deep brain of COPD patients and healthy controls after supplementary oxygen inhalation. After oxygen delivery, the ALFF value of basal ganglia and right thalamus significantly increased in the control group (a), but not in the COPD group (b)](BRB3-9-e01336-g004){#brb31336-fig-0004}

4. DISCUSSION {#brb31336-sec-0019}
=============

The COPD patients mainly exhibited declines in the executive function, while the function of long‐term memory (Delayed CFT and AVLT) is comparable between the two groups. This result is largely coincided with the finds of Dodd et al. and Cleutjens et al. (Cleutjens, Franssen, et al., [2017](#brb31336-bib-0004){ref-type="ref"}; Dodd et al., [2012](#brb31336-bib-0009){ref-type="ref"}). The affected domains indicate that the COPD mainly associated with na‐MCI rather than a‐MCI, which is also supported by the results of previous studies (Singh et al., [2014](#brb31336-bib-0029){ref-type="ref"}; Villeneuve et al., [2012](#brb31336-bib-0035){ref-type="ref"}). Another interesting finding is that it takes longer time for COPD patients to copy a complicated line drawing in the recognition section of the CFT than normal control. This result reminds us of a previous study reporting that drawing ability could predict mortality and was uniquely associated with mortality in severe COPD (Antonelli‐Incalzi et al., [2006](#brb31336-bib-0025){ref-type="ref"}).

Our study demonstrates more extensive WMC in the COPD patients compared to normal controls. Impaired white matter microstructural integrity in COPD patients has been reported by many studies (Dodd et al., [2012](#brb31336-bib-0009){ref-type="ref"}; Spilling, Jones, Dodd, & Barrick, [2017](#brb31336-bib-0031){ref-type="ref"}); van Dijk et al., [2004](#brb31336-bib-0034){ref-type="ref"}). However, the results of GM volume change reported by previous studies are inconsistent (Dodd et al., [2012](#brb31336-bib-0009){ref-type="ref"}; Esser et al., [2016](#brb31336-bib-0014){ref-type="ref"}; Spilling et al., [2017](#brb31336-bib-0031){ref-type="ref"}; Wang et al., [2017](#brb31336-bib-0036){ref-type="ref"}). Some studies revealed that there existed regional or global brain atrophy in COPD patients (Esser et al., [2016](#brb31336-bib-0014){ref-type="ref"}; Wang et al., [2017](#brb31336-bib-0036){ref-type="ref"}), while other studies did not find a significant difference in GM volume between COPD patients and normal controls (Dodd et al., [2012](#brb31336-bib-0009){ref-type="ref"}; Spilling et al., [2017](#brb31336-bib-0031){ref-type="ref"}). In our study, the COPD patients did not demonstrate a significant different GM or WM volume when compared to normal controls. In our opinion, severe hypoxemia will finally lead to brain atrophy as reflected by the chronic phase of hypoxic‐ischemic brain injury (Heinz & Rollnik, [2015](#brb31336-bib-0019){ref-type="ref"}; Weiss, Galanaud, Carpentier, Naccache, & Puybasset, [2007](#brb31336-bib-0037){ref-type="ref"}), while brain atrophy may not be prevalent in the stable COPD patients. Meanwhile, a rigid multiple comparison correction method adopted in our statistical tests may also account for the negative result (Eklund, Nichols, & Knutsson, [2016](#brb31336-bib-0013){ref-type="ref"}).

The decreased ALFF of BOLD signal in deep brain could be related to altered neurovascular coupling and suppressed spontaneous neuronal activity under chronic hypoxia environment. One study demonstrated that the magnitude of task‐related BOLD response varied with the region of the brain under hypoxia (Dunn, Wadghiri, & Meyerand, [1999](#brb31336-bib-0011){ref-type="ref"}). In our study, the basal ganglia nuclei were most sensitive to mild hypoxia regarding ALFF measurement, which is due to its anatomical position. However, it is also important to know that lower PaO~2~ implies lower oxyhemoglobin and higher deoxyhemoglobin in the blood, which lead to a lower baseline signal intensity in the T2‐star weighed BOLD‐fMRI images. The time cost for CFT recognition is associated with motor function and executive function (Royall, [2006](#brb31336-bib-0026){ref-type="ref"}). It is well‐accepted that the damage of basal ganglia is responsible for the motor function impairment in the basal ganglia stroke patients. Moreover, basal ganglia is also involved in the executive function including working memory and decision‐making (Helie, Ell, & Ashby, [2015](#brb31336-bib-0020){ref-type="ref"}; Schroll & Hamker, [2013](#brb31336-bib-0027){ref-type="ref"}). Furthermore, there exists a significant correlation between ALFF signal and PaO~2~. Thus, there is a possibility that decreased ALFF value in the bilateral basal ganglia may directly owing to the lower PaO~2~and may be associated with the suppressed neuronal activity leading to motor and/or executive function impairment. Also, impairment of pulmonary ventilation function may be the original cause of the fMRI findings and CI because of the highest correlation coefficient between FEV1%pred and other aberrant pathophysiology indexes.

Oxygen therapy is a common treatment for COPD patients with moderate to severe hypoxemia. Short‐term oxygen inhalation increased the PaO~2~ in the COPD patients and leads to moderate hyperoxia in normal controls (Prieur et al., [1998](#brb31336-bib-0024){ref-type="ref"}). There are some studies reporting elevated BOLD signal intensity in rats and humans under hyperoxia (Losert, Peller, Schneider, & Reiser, [2002](#brb31336-bib-0023){ref-type="ref"}; Sicard & Duong, [2005](#brb31336-bib-0028){ref-type="ref"}), and elevated baseline BOLD signal increases the ALFF value mathematically. The unchanged ALFF signal in the deep brain of COPD patients should be interpreted with caution. There have been an adaptive change of neurons in deep brain nuclei under long‐term mild hypoxia, which leads to the amplitude of such low‐frequency (0.01--0.1) BOLD signal fluctuation remain unchanged. Alternatively, it is also possible that ALFF does not change so sensitively to the increase in PaO~2~in a relatively lower range in COPD patients. A recent study claims that the cerebral vasculature of COPD patients is insensitive to low‐flow oxygen delivery because of the unaltered CBF (Hoiland et al., [2018](#brb31336-bib-0021){ref-type="ref"}). There are some reports indicating that long‐term oxygen treatment will not improve the survival of COPD patients with moderate resting hypoxemia (Chaouat et al., [1999](#brb31336-bib-0003){ref-type="ref"}; Gorecka, Gorzelak, Sliwinski, Tobiasz, & Zielinski, [1997](#brb31336-bib-0018){ref-type="ref"}). It will be interesting to investigate whether the unchanged ALFF value in deep brain nuclei of COPD patients could be related to these results.

There is a limitation that we did not evaluate the possible neurovascular coupling change of the COPD patients so that we could not reach a conclusion about the exact underlying mechanism of the altered ALFF in the deep brain of these patients. However, a recent report revealed unaltered neurovascular coupling under moderate hypoxia (Decroix et al., [2018](#brb31336-bib-0008){ref-type="ref"}). Another limitation of this study is that the sample size is too small for the oxygen inhalation data analysis, which may not be able to reveal the real effect of oxygen inhalation in COPD patients. Finally, interpretation of the relationship between altered ALFF and other clinical indexes is difficult since most of the correlations were nonsignificant in separate groups. Notably, some old COPD patients showed difficulty in focusing on cognitive tasks for a long time, which limit the accuracy of the neuropsychological tests. This can also ultimately lead to a relatively lower correlation coefficient between altered ALFF and scores of the tests.

In conclusion, this study supports the association between COPD and na‐MCI and highlights the executive function impairment in COPD patients. Our study also revealed the aberrant ALFF alteration in the deep brain of these patients, and this alteration may be directly related to the PaO~2~ changes and play a role in the CI of these COPD patients.
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